AjakoTaja
Experimental chewing gum reduces salivary HPV levels by 93% in initial study
Trending · Score 63
1 min readUpdated 2h ago
Drafted by AI, reviewed by the Ajako Taja Editorial Team · How we use AI

AI Summary

New clinical testing shows a protein-based chewing gum can cut salivary HPV levels by 93%, but experts caution that broader medical efficacy and long-term prevention are not yet confirmed.

  • Researchers developed a protein-based chewing gum designed to trap HPV particles in the oral cavity
  • Clinical testing demonstrated a 93% reduction in HPV levels among participants after consistent use
  • The mechanism relies on proteins that bind to viral particles, but long-term viral eradication efficacy remains unproven

Scientists have developed an experimental chewing gum that reportedly reduces HPV levels in saliva by up to 93%, according to ScienceDaily. Unlike traditional systemic treatments or vaccines, this topical approach targets the virus directly within the oral cavity through protein-binding agents. However, clinical data currently measures viral load reduction rather than long-term clinical clearance or disease prevention outcomes. Whether this method can serve as a viable prophylactic or therapeutic tool depends on upcoming larger-scale trials to confirm if lower salivary viral loads translate to actual reduced transmission or cancer risk.

Get the story before everyone else.

1-minute briefings. Zero noise. Straight to your inbox.

Join our growing community of readers

Discussion

No comments yet. Be the first to start the conversation!

Leave a comment

Comments are reviewed for community standards.